Intelligent Parkinson early detection guiding novel supportive interventions
Description
Parkinson’s desease is a progressive disease that is caused mainly by the loss of brain cells responsible for the production of a brain chemical, called dopamine, along with involvement of at least three other chemicals (serotonin, acetylcholine and noradrenaline). Varying Symptoms are experienced by patients and do not include only the common tremor and other motor symptoms. In fact, the early ones are constipation, reduced ability to smell, sleep problems, depression and pain. No definite early detection laboratory tests have been established for Parkinson’s. The very early symptoms (movement and not movement-related) are often missed. i-PROGNOSIS, aims to advance the way Parkinson’s disease is prognosed and treated by combining technology with medical expertise. Eleven partners, academic institutions and companies, from six EU countries, led by Aristotle University of Thessaloniki, Greece, have joined forces for i-PROGNOSIS in order to provide technology-based solutions against Parkinson’s, as well as raise awareness on the disease and self-health management.Project Consortium
- Coordinator: Aristoteleio Panepistimio Thessalonikis (Greece)
- Center for Research and Technology Hellas (Greece)
- Microsoft Innovation Center Greece (Greece)
- COSMOTE Mobile Telecommunications S.A. (Greece)
- Age Platform Europe (Belgium)
- Technische Universitat Dresden (Germany)
- Fraunhofer (Germany)
- Faculdade de Motricidade Humana (Portugal)
- PLUX – Wireless Biosignals S.A. (Portugal)
- Karolinska Institutet (Sweden)
- King’s College London, King’s College Hospital (United Kingdom)